Why the study?
TMVR as a rescue therapy with concurrent cerebral protection device use in a patient with acute ischaemic MR, cardiogenic shock, and left atrial appendage thrombus had not been reported.
TMVR with concurrent use of a cerebral protection device may be a feasible rescue therapy for inoperable patients with cardiogenic shock from acute severe mitral regurgitation and concurrent LAA thrombus.
Answers are grounded in this paper and cite their sources.
Suggests feasibility of TMVR with CPD in acute ischaemic MR, shock and LAA thrombus; leaves open need for prospective validation.
BACKGROUND: Transcatheter mitral valve repair (TMVR) in patients with severe acute mitral regurgitation (MR) and high surgical risk has been described. Moreover, the use of cerebral protection device (CPD) during TMVR in patients without evidence of intracardiac thrombus has been investigated. To the best of our knowledge, TMVR as a rescue therapy in a patient with acute ischaemic MR, cardiogenic shock, and left atrial appendage (LAA) thrombus with concurrent use of CPD has not been reported. CASE SUMMARY: A 59-year-old female with subacute lateral myocardial infarction caused by subacute stent thrombosis after stent implantation in the left circumflex artery 3 weeks previously presented with acute heart failure due to acute severe MR at a peripheral hospital. The patient was transferred to our tertiary centre for operative mitral valve repair. Transoesophageal echocardiogram revealed the presence of LAA thrombus. During the admission, the patient developed an electrical storm and cardiogenic shock. Because of the extremely high surgical risk and the lack of other therapeutic options, the patient was treated with TMVR (MitraClip™, Abbott Structural Heart Devices, Santa Clara, CA, USA) with the use of CPD (Sentinel™; Boston scientific) as a rescue therapy. After the procedure, the clinical and haemodynamic conditions of the patient improved significantly, and she could be discharged home without any neurological sequelae. CONCLUSION: TMVR with concurrent use of CPD as a rescue therapy may be considered in non-operable patients with cardiogenic shock caused by acute severe MR and evidence of LAA thrombus when no other therapy options are possible.
No takes yet. Share an insight, caveat, or question.
Alachkar et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: